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Pericardial fatAbstract Objectives: To assess the influence of age on the association of pericardial fat volume
(PFV), weight and body mass index (BMI) with coronary stenosis, plaque and coronary artery
calcification (CAC).
Materials and methods: A total of 127 consecutive patients with intermediate pretest probability of
ischemic heart disease who underwent CT angiography examination were enrolled in this study. Of
these, only 86 patients were found to be eligible to enroll in this study.
Results: Statistical analysis was performed in two steps. First we studied the relationship of anthro-
pometric measures and coronary atherosclerotic markers in the whole sample. Second, we classified
the patients into two groups according to age: age 650 group [30 patients, 18 (60%) male, 12 (40%)
female with age <50 years] and age >50 group [56 patients, 38 male (68%), 18 female (32%) with
age above 50 years]. PFV was significantly associated with coronary artery stenosis (r= 0.381,
P= 0.00) and this association persisted even after dividing the patients into young and older age
group while there was inconsistent relationship between PFV and coronary plaque. There was a sig-
nificant association between PFV and CAC in older age group only (P= 0.03). Weight and body
mass index failed to demonstrate a significant association with coronary atherosclerotic markers in
both young and older age groups.
Conclusion: Weight and BMI showed no significant correlation with coronary atherosclerotic
markers while PFV as a new imaging marker for obesity showed a significant correlation with coro-
nary atherosclerotic markers particularly stenosis severity.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Egyptian Society of
Cardiology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
There is a substantial increase in cardiovascular burden in the
elderly and the predictive value of cardiac risk score and risk
factors diminishes significantly with advancing age. Hence,
the introduction of new non-invasive imaging biomarkers to
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mount importance in primary and secondary prevention.1
On the other hand, coronary artery disease occurs less fre-
quently in young with different cardiac risk profiles and long
term prognosis compared to elderly patients.2,3
Body mass index (BMI) and weight are classical anthropo-
metric measures used in large epidemiological and clinical
studies to define obesity, metabolic syndrome and estimate
the risk of cardiovascular disease.4
Pericardial fat, as a new marker of atherosclerosis is an adi-
pose tissue surrounding the heart and epicardial coronary
arteries with reported influence on coronary circulation via
local secretion of numerous pro-inflammatory hormones and
cytokines.5–8
The main aims of this study were to investigate the influ-
ence of age on the association of emerging biomarker of obe-
sity (pericardial fat volume) and classical anthropometric
measures of obesity with coronary atherosclerotic markers in
patients with intermediate pretest probability of ischemic heart
disease assessed by coronary CT angiography.2. Patients and methods
This cross sectional study was carried out in the Cardiology
center between January and July 2013. All patients gave their
written informed consent for taking part in this study. The
study was approved by Ethical Committee of our institute.
Exclusion criteria for multi-detector CT examination included
a history of cardiac surgery, iodine-based contrast allergy,
renal failure (creatinine, >1.5 mg/dL), atrial fibrillation or
other unstable heart rhythm, inability to perform breath-
holding, hemodynamically unstable patients, presence of
intracardiac devices (pacemaker or ICD), pregnant women
and contraindications for beta blocker use. A total of 127
consecutive Iraqi patients with intermediate pretest probabil-
ity of ischemic heart disease based on their age, sex and car-
diac symptoms who underwent 64 multi-slice multi-detector
CT angiography examinations for assessment of coronary
artery disease were enrolled in this study. 41 patients were
excluded due to missing or losing of data (31 patients), poor
examination technique (6 patients) and difficulty in accurate
pericardial fat volume calculation or segmentation of fat (4
patients). Only 86 patients (56 patients > 50 years and
30 patients 6 50 years) were found to be eligible to enroll in
this study.
A standardized questionnaire was employed by physicians
at the time of coronary CT angiography examination to obtain
a history of conventional cardiac risk factors for coronary dis-
ease from each patient including a positive family history of
premature atherosclerosis (occurring in men before the age
of 55 years and before the 65 years in women), current smok-
ing history (more than 10 cigarettes per day in the last year),
a history of hypertension, or use of anti-hypertension medica-
tions; hyperlipidemia was defined as total cholesterol
P200 mg/dl or triglyceride levels P150 mg/dl or use of lipid
lowering drugs; a history of diabetes mellitus or use of insulin
or diabetic lowering drugs and body mass index was calculated
as weight in kg/height squared in meters. Patient with 2 and
more of cardiac risk factors was labeled as having multiple risk
factors.For coronary CT analysis, calcified plaques were defined as
a structure of >1 mm consisting of only calcium within and/or
adjacent to vessel lumen.
Severity of coronary artery stenosis was visually graded as
non-significant stenosis with a mean lumen diameter reduction
of <50% or significant stenosis with a mean lumen diameter
reduction ofP50% in a single vessel by comparing the lumen
diameter of the narrowest segment with that of a more proxi-
mal or distal normal segment in two orthogonal projections.
Calcium score was categorized as 0 (no calcification), 1–9
(minimal calcification), 10–99 (mild), 100–399 (moderate)
and P400 (extensive calcification).
3. CT scan protocol and pericardial fat volume quantification
CT coronary angiography was performed with a 64-slice scan-
ner (Aquillon 64, V4.51 ER 010, Toshiba Medical Systems,
Tochigi, Japan) with retrospective electrocardiography
(ECG) gating. Before Multi-Slice CT angiography, a non-
contrast CT was acquired to measure calcium score according
to the Agatston method using sequence scan with slice thick-
ness of 3 mm. When the patient heart rate was less than
65 bpm, a b-blocker (metoprolol 20–60 mg orally) was admin-
istered before the scan. A bolus of 80 ml contrast medium
(Omnipaque, 350 mg/mL iodine) was injected intravenously
at a rate 5 ml/s, followed by 30 mL of normal saline. The scan
was obtained from the aortic arch to the level of the diaphragm
during a single breath hold. With ECG triggered scanning pro-
tocol was performed, and the following parameters were used:
collimation width 32.5  32.5 cm, slice thickness 0.5 mm, rota-
tion time 0.35 s, tube voltage 120 kV, maximum effective tube
current 890 mA, table feed 0.3 mm/rotation. Examination time
was about 10 s.
CT images were reconstructed using a smooth kernel (B25f)
with a slice thickness of 0.5 mm (increment 0.3 mm). CT data
sets were transferred to dedicated workstation (Vitrea 2 work-
station vital image Plymouth, Minnesota, USA) for image
analysis.
Pericardial fat volume was defined as any fat tissue located
within pericardial sac and measured three-dimensionally with
the contrast-enhanced phase. The layer of the pericardium
was manually traced and a three-dimensional image of the
heart was constructed. Then the pericardial fat volume was
quantified by calculating the total volume of the tissue whose
CT density ranged from 250 to 20 HU within the peri-
cardium by using three D workstation statistical analysis. All
MDCT images were assessed by two independent radiologists
with more than 5 years’ experience in coronary MDCT angiog-
raphy interpretation
3.1. Statistical analysis
Data are presented as mean ± standard deviation or as num-
ber with percentages. Categorical data are expressed as fre-
quencies and were compared with Pearson’s Chi-square test.
Continuous variables are presented as the mean ± standard
deviation and were compared using Student’s t test or
ANOVA. Pearson’s correlation coefficient was used to esti-
mate the correlation of continuous variables. All data were col-
lected and analyzed with SPSS for MAC version 17 (IBM,
Table 2 Correlation of anthropometric measures with coro-
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was considered statistically significant.nary atherosclerotic markers.
CAC Coronary stenosis Coronary plaque
Weight r 0.009 0.09 0.219
P 0.9 0.38 0.05
BMI r 0.048 0.02 0.047
P 0.65 0.9 0.66
PFV r 0.194 0.395 0.232
P 0.07 0.00 0.032
The values in bold indicates the significant correlation observed
between PFV with coronary artery stenosis and coronary plaque
presence.
Figure 1 No significant association between pericardial fat
volume (PFV) and coronary artery calcification (CAC) in the
whole sample.4. Results
The statistical analysis is performed in two steps:
First we studied the relationship of anthropometric mea-
sures and coronary atherosclerotic markers in the whole
sample (86 patients).
Second, we classified the patients into two groups: patients
aged 650 years group containing 30 patients, 18 (60%)
male, 12 (40%) female (mean age 44 ± 4 years) and
patients aged >50 years group containing 56 patients, 38
male (68%), 18 female (32%) (mean 60 ± 6 years). The
clinical characteristics of the patients enrolled in the study
are shown in Table 1.
In first step analysis, PFV was significantly associated
with significant coronary artery stenosis and coronary
calcified plaque presence while there was no significant
association between PFV and CAC as in Table 2 and
Fig. 1.
Body weight and BMI failed to demonstrate a significant
association with any of coronary atherosclerotic markers as
in Table 2.
4.1. Patients aged 650 years group
Mean and median values of PFV were 113 ± 72 and 100
respectively and range from 17 to 283 cm3. The median value
of PFV had been used as a cut-off value to separate younger
age patients into two subgroups for statistical analysis [low
pericardial fat volume (PFV1 < 100 cm3) group and high peri-
cardial fat volume (PFV2P 100 cm3) group]. Mean bodyTable 1 Patients characteristics.
Parameter Total number
(mean ± SD or %)
Age 650 group number
(mean ± SD or %)
Age >50 group number
(mean ± SD or %)
P value
Age (mean ± SD) 54.7 ± 9 44 ± 4 60 ± 6
Male 56 (65) 18 (60) 38(68) 0.46
Female 30 (35) 12 (40) 18 (32) 0.46
Risk factors
Hypertension 39 (45) 11 (37) 28 (50) 0.23
Diabetes 6 (7) 3 (10) 3 (5) 0.42
Hyperlipidemia 21 (24) 9 (30) 12 (21) 0.37
Smoking 17 (20) 5 (17) 12 (21) 0.59
Family history 8 (9) 6 (20) 2 (3) 0.012
BMI P30 25 (29) 9 (30) 16 (28) 0.88
Multiple 29 (33.5) 10 (33) 19 (34) 0.95
CAC
0 34 (39.5) 15(50) 19 (34) 0.14
1–9 8 (9) 2 (7) 6 (11) 0.5
10–99 23 (27) 9 (30) 14 (25) 0.6
100–399 17 (20) 3 (10) 14 (25) 0.09
P400 4 (4.5) 1 (3) 3 (5) 0.6
PFV (mean) 123.5 ± 7.7 cm3 113 ± 72 cm3 128.9 ± 71 cm3
PFV (median) 107 cm3 100 cm3 110 cm3
Table 3 Correlation of pericardial fat volume (PFV), body
mass index and body weight with coronary atherosclerotic
markers in age 6 50 group.
CAC Stenosis Plaque
BMI r 0.009 0.066 0.354
P 0.9 0.2 0.051
Weight r 0.122 0.054 0.132
P 0.7 0.2 0.8
PFV r 0.1 0.16 0.11
P 0.6 0.02 0.2
Table 4 Correlation of pericardial fat volume (PFV) body
mass index (BMI) and body weight with coronary atheroscle-
rotic markers in old age group.
CAC Stenosis Plaque
BMI r 0.082 0.034 0.103
P 0.5 0.8 0.28
Weight r 0.005 0.022 0.122
P 0.9 0.8 0.2
PFV r 0.21 0.25 0.11
P 0.03 0.002 0.06
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body weight was 77.8 ± 10 kg and range from 46 to 100 kg.
The clinical characteristics of the patients enrolled in the study
are shown in Table 1.
There were no statistically significant differences in the dis-
tribution of cardiac risk factors between the two groups except
for a family history of premature coronary disease that was
more prevalent in patients aged 650 years group (P= 0.012).
Regarding the correlation of PFV with coronary
atherosclerotic markers, PFV was significantly associated with
coronary artery stenosis (P= 0.02) while there was no signif-
icant association between PFV with coronary calcified plaque
presence and CAC (P= 0.2 and 0.6 respectively) as in Table 3
and Fig. 2.
Regarding the correlation of body mass index and coronary
atherosclerotic markers, no significant association was
reported between body mass index and coronary artery steno-
sis, calcified plaque presence and CAC (P= 0.2, 0.051 and 0.9
respectively) as in Table 3.
Similarly, no significant association was demonstrated
between body weight and coronary artery stenosis, calcified
plaque presence and CAC (P= 0.2, 0.8 and 0.73 respectively)
as in Table 3.Figure 2 No significant association between pericardial fat
volume (PFV) and coronary artery calcification (CAC) in patients
aged 650 years (P= 0.6).4.2. Patients aged >50 years group
Mean and median values of PFV were 128.9 ± 71 cm3 and
110 cm3 respectively and range from 20 to 367 cm3. The med-
ian value of PFV in older age group had been used as a cut-off
value to separate patients into two subgroups for statistical
analysis [low pericardial fat volume (PFV1 < 110 cm3) and
high pericardial fat volume (PFV2P 110 cm3) group]. Mean
BMI was 27 ± 4 and range from 20 to 37. Mean body weight
was 74 ± 11 kg and range from 55 to 110 kg.
Regarding the association of PFV and coronary
atherosclerotic markers, there was a significant association
between PFV with coronary artery stenosis and CAC
(P= 0.002 and 0.03 respectively) while there was no signifi-
cant association between PFV and coronary plaque presence
(P= 0.06) as in Table 4.
Regarding association of BMI and coronary atherosclerotic
markers, no significant association was observed between body
mass index and coronary artery stenosis, calcified plaque pres-
ence and CAC (P= 0.8, 0.2 and 0.5 respectively) as in Table 4.
Similarly no significant association was observed between
body weight and coronary artery stenosis, calcified plaque
and CAC (P= 0.8, 0.2 and 0.9 respectively) as in Table 4.5. Discussion
PFV was significantly associated with coronary artery stenosis
and coronary calcified plaque while there was no significant
association between PFV and CAC.
After splitting the patients into 2 groups according to the
age, PFV remained significantly associated with coronary
stenosis but only with CAC in patients aged >50 while there
was no significant association between PFV and coronary cal-
cified plaque in both younger and older age groups.
Currently, there is no consensus regarding the upper limit
of normality for pericardial fat thickness or volume and the
reported values are highly variable among different patient
populations and studies due to discrepancies and ambiguities
in the definition and nomenclature of fat deposits around the
heart.9
Two important population-based studies have reported the
association between cardiac fat deposits and coronary artery
stenosis highlighting the metabolic role of pericardial fat in
coronary atherosclerotic process independent of cardiac risk
factors.10,11
Obesity and atherosclerosis 107The findings of these studies support the bio-imaging role
of pericardial fat deposits as a modulator of coronary
atherosclerosis burden.
The differences in anatomic description (pericardial versus
epicardial fat) and measurement techniques (volume or thick-
ness) may be attributed to non significant correlation of peri-
cardial fat volume with coronary calcium score in our study
and it is possible that a volume measurement of cardiac
fat by CT imaging may be different from a linear measure
by echocardiography in the correlation with coronary
calcification.6
Pericardial fat volume increment has been observed to have
a strong association with various inflammatory markers
changes and early coronary endothelial dysfunction that may
precede coronary calcification and the development of mature
atherosclerotic changes while the coronary calcium score has
been reported to have a weak relationship with these inflam-
matory markers and endothelial changes revealing that the
presence of mere coronary calcification could represent a
stable phase of atherosclerosis and pericardial fat on the other
hand may be more strongly associated with an active
process.12,13
However, it has been postulated that coronary calcification
may reflect the life time influence of all cardiac risk factors on
coronary wall and the presence of coronary calcification in
elderly is a sensitive but unspecific finding.14
This might explain the association of PFV and CAC only in
patients older than 50 years in our study.
Regarding the inconsistent relationship of PFV and coro-
nary calcified plaque presence in our results, several studies
have been reported that plaque morphology differs by age
and gender and young patients tend to have significantly lower
plaque burden.15–17
Moreover, it has been hypothesized that the mechanism of
coronary artery disease in young patients is characterized by
single vessel disease caused by acute plaque rupture combined
with coronary vasospasm.17
However, a current study by Davidson et al. demonstrates
that a significant intracoronary thrombus may be observed in
young patients with acute coronary syndrome who had no
angiographically apparent coronary disease highlighting the
role of acute de novo thrombosis and endothelial dysfunction
in coronary disease pathogenesis in young.18
Russo et al. have been reported that fatal cardiac events
may arise from the rupture of soft non-stenotic plaques that
remain undetected by routine noninvasive tests or angio-
graphic procedures and presence of non calcified plaques
appear to be independent predictors of cardiac events regard-
less of the luminal narrowing (p< 0.0001).19
Moreover, it has been reported that coronary artery disease
may result from acute non calcified plaque rupture and calcifi-
cation is a marker of plaque stability.20
Interestingly, the relationship between PFV and the severity
of coronary artery stenosis assessed by computed tomography
and angiography was investigated in the cohort of the Korean
Atherosclerosis Study 2 (n= 402, mean age of 54 years, 57.0%
men) and found that calcified plaque was not related to peri-
cardial fat but mixed and non-calcified plaques tended to
increase along with pericardial fat burden supporting the idea
that pericardial fat deposits could be already present before
plaque calcification and it may precede the development of
coronary artery disease.21The inconsistencies in relationship between the coronary
calcified plaque and PFV may be attributed to the difference
in racial and ethnic background of population who have been
enrolled in the studies and the selection criteria for inclusion.
In our study, BMI and body weight were failed to demon-
strate a significant relationship with coronary atherosclerotic
markers in the whole sample of our patients and even after
dividing the patients into younger and older age groups.
There is paucity in data regarding the prevalence of obesity
and its relation to cardiovascular disease in Iraq and surround-
ing countries despite the global increase in obesity prevalence.
According to 2010 WHO statistics, the prevalence of obe-
sity in United State was 44–48% while in Iraq 14% of male
and 19% of female were classified to be obese.22
The relationship of PFV to other anthropometric measures
is known to be weak and body mass index or waist circumfer-
ence may not adequately reflect the actual visceral fat accumu-
lation that is reported to be metabolically active organs or to
completely estimate the true risk of cardiovascular disease.23,24
Moreover, body weight and body mass index may represent
different amounts of visceral adipose volume in different racial
and ethnic groups suggesting that racial and ethnic influence
the relationship between the classical obesity measures with
PFV or cardiovascular disease.4
Mazurek et al. performed biopsies of the cardiac fat and
subcutaneous adipose tissue of patients referred for elective
coronary artery bypass surgery and found a higher expression
of inflammatory markers in the pericardial fat, but not in the
subcutaneous adipose tissue highlighting the active metabolic
role of local cardiac adipose tissue.25
There were several limitations in this study:
First, the population was nonrandomly selected since it
involved only patients with intermediate pretest probability
of ischemic heart disease suggesting a possibility of selec-
tion bias. Second, The number of patients was relatively
small particularly when the study population is divided in
subgroups. Third, we did not have invasive angiographic
data in our patients to further describe and confirm coro-
nary artery disease severity. Fourth, our algorithm for
quantifying pericardial fat volume was not completely
automatic and still required user interaction.
Larger studies with follow-up are needed to further investi-
gate the role of pericardial fat deposits as an imaging mar-
ker for obesity and coronary atherosclerosis with
prognostic significance in both young and old age patients.
6. Conclusion
Body weight and BMI as an obesity measures failed to demon-
strate a significant relationship with coronary atherosclerotic
markers while PFV as an emerging marker for obesity and
atherosclerosis showed a significant association with coronary
stenosis and CAC particularly in older age patients, these find-
ings support the role of PFV as a bio-imaging tool for obesity
and coronary atherosclerotic burden.
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